The use of live attenuated influenza vaccine (LAIV) in healthcare personnel (HCP): guidance from the Society for Healthcare Epidemiology of America (SHEA)
| Autor: | Gregory A. Poland, Michael L. Tapper, Lisa L. Maragakis, Thomas R. Talbot, David J. Weber, Deborah J. Cotton, Edward Septimus, Hilary M. Babcock |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Microbiology (medical)
medicine.medical_specialty Pediatrics Epidemiology Health Personnel Population Vaccines Attenuated Health care Influenza Human Medicine Live attenuated influenza vaccine Infection control Humans education education.field_of_study Infection Control business.industry United States Virus Shedding Influenza B virus Infectious Diseases Influenza A virus Influenza Vaccines Family medicine Practice Guidelines as Topic business |
| Zdroj: | Infection control and hospital epidemiology. 33(10) |
| ISSN: | 1559-6834 |
| Popis: | Because of the live viral backbone of live attenuated influenza vaccine (LAIV), questions have arisen regarding infection control precautions and restrictions surrounding its use in healthcare personnel (HCP). This document provides guidance from the Society for Healthcare Epidemiology of America regarding use of LAIV in HCP and the infection control precautions that are recommended with its use in this population.Infect Control Hosp Epidemiol 2012;33(10):981-983 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|